4.5 Article

Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers

J. Van Laethem et al.

Summary: This study retrospectively analyzed antibiotic consumption in COVID-19 patients in a Belgian university hospital and identified drivers associated with antibiotic prescribing, such as fever on admission and lower SpO(2)/FiO(2) ratio. Specific patient characteristics, like underlying pulmonary disease, and hospital stay duration were also linked to antibiotic prescription. The findings aim to guide antimicrobial stewardship programs in optimizing interventions in COVID-19 wards.

INTERNAL AND EMERGENCY MEDICINE (2022)

Article Infectious Diseases

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Carolina Garcia-Vidal et al.

Summary: The study found that co-infections and superinfections in hospitalized COVID-19 patients were relatively low compared to other viral pandemics. Patients experienced worse outcomes after hospital-acquired superinfections occurred.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Immunology

Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study

Valerie M. Vaughn et al.

Summary: Among 1705 hospitalized COVID-19 patients, 56.6% received early empiric antibacterial therapy, while only 3.5% had confirmed community-onset bacterial infections. The use of early empiric antibacterials varied widely across hospitals.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline

Elske Sieswerda et al.

Summary: The Dutch Working Party on Antibiotic Policy formed a multidisciplinary expert committee to provide evidence-based recommendations for antibacterial therapy in hospitalized adults with COVID-19. The committee suggested restrictive antibiotic use upon admission and outlined specific criteria for stopping antibiotic treatment. The study emphasized the importance of laboratory tests in guiding antibiotic therapy.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Editorial Material Infectious Diseases

Understanding the role of bacterial and fungal infection in COVID-19

Timothy M. Rawson et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Public, Environmental & Occupational Health

Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team

Milner B. Staub et al.

Summary: Antimicrobial use increased initially for COVID-19 patient care teams compared to pre-COVID-19 levels, but significantly decreased after implementation of a multispecialty clinical guidance team, which may be an effective strategy to reduce unnecessary antimicrobial use.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2021)

Article Infectious Diseases

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D. Russell et al.

Summary: Microbiologically confirmed bacterial infections are rare in patients admitted with COVID-19, mostly being secondary infections. Gram-negative organisms and S aureus are the predominant pathogens. Antimicrobial use is frequent, but can be intervened with stewardship measures.

LANCET MICROBE (2021)

Review Infectious Diseases

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

Bradley J. Langford et al.

Summary: The study estimated that approximately three-quarters of patients with COVID-19 receive antibiotic treatment, which is significantly higher than the estimated prevalence of bacterial co-infection. This suggests a potential for high rates of unnecessary antibiotic use in patients with COVID-19.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Letter Medicine, General & Internal

Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit

Charlotte Vanhomwegen et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2021)

Review Emergency Medicine

Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis

Timotius Ivan Hariyanto et al.

Summary: The meta-analysis suggests that COVID-19 patients with elevated procalcitonin, CRP, D-dimer, and LDH levels, as well as decreased albumin levels, may be more likely to develop severe outcomes.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Microbiology

Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019

Michael May et al.

Summary: The role of procalcitonin in identifying community-associated bacterial infections among patients with coronavirus disease 2019 is not yet established. Procalcitonin did not reliably identify bacterial coinfections, but may be useful in excluding bacterial infection.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Review Multidisciplinary Sciences

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis

Jackson S. Musuuza et al.

Summary: Our study found that as many as 19% of patients with COVID-19 had co-infections and 24% had superinfections. The presence of either co-infection or superinfection was associated with poor outcomes, such as increased mortality.

PLOS ONE (2021)

Article Immunology

Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections

Christine J. Kubin et al.

Summary: In this study, 3028 adult patients hospitalized with COVID-19 were evaluated, with 17% of them experiencing secondary infections and 12% of them classified as health care-associated infections (HAIs). Gram-negative bacteria and fungi were the most common pathogens causing HAIs, and antibiotic resistance increased with prolonged hospital stays. Intensive care unit stay, mechanical ventilation, and steroid use were identified as risk factors for HAIs.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission

Natasha N. Pettit et al.

Summary: This study aimed to evaluate the impact of guideline implementation for CABP antibiotics in COVID-19 patients. Following the intervention, there was a decrease in antibiotic prescribing, shortened duration of therapy, and a significant increase in guideline-congruent empiric antibiotic initiation.

BMC INFECTIOUS DISEASES (2021)

Article Infectious Diseases

An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London

Liyang Wang et al.

Summary: The study found that bacterial co-infection was rare in COVID-19 patients within 48 hours of hospital admission. Most patients received empirical antibiotic treatment, and there were no significant differences in age, gender, comorbidities, ICU admission, and 30-day all-cause mortality between patients with and without bacterial co-infections. However, patients with bacterial co-infections had significantly higher inflammatory markers.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Medicine, General & Internal

Quantitative Assessment of Chest CT Patterns in COVID-19 and Bacterial Pneumonia Patients: a Deep Learning Perspective

Myeongkyun Kang et al.

Summary: The study proposed a method to distinguish between COVID-19 and bacterial pneumonia patients, as well as to classify severity, by constructing lesion clusters and histogram features. The method showed good performance in diagnostic accuracy and severity classification, with potential clinical applications.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Editorial Material Infectious Diseases

COVID-19: don't neglect antimicrobial stewardship principles!

B. D. Huttner et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Letter Public, Environmental & Occupational Health

Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck

Michael P. Stevens et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Infectious Diseases

COVID-19 and the potential long-term impact on antimicrobial resistance

Timothy M. Rawson et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Review Infectious Diseases

Co-infections in people with COVID-19: a systematic review and meta-analysis

Louise Lansbury et al.

JOURNAL OF INFECTION (2020)

Review Medical Laboratory Technology

Predicting Disease Severity and Outcome in COVID-19 Patients

Youley Tjendra et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)

Letter Infectious Diseases

Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients

Priya Nori et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Letter Infectious Diseases

Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics

Chien-Yi Chang et al.

JOURNAL OF INFECTION (2020)

Article Biochemistry & Molecular Biology

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane Marie Del Valle et al.

NATURE MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Chest CT in COVID-19: What the Radiologist Needs to Know

Thomas C. Kwee et al.

RADIOGRAPHICS (2020)

Article Public, Environmental & Occupational Health

A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit

Stefanie Kampmeier et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)

Article Infectious Diseases

Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection

Liam Townsend et al.

JAC-ANTIMICROBIAL RESISTANCE (2020)

Review Infectious Diseases

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis

Eili Y. Klein et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2016)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Respiratory System

Dysphagia, dystussia, and aspiration pneumonia in elderly people

Satoru Ebihara et al.

Journal of Thoracic Disease (2016)

Review Infectious Diseases

Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis

Shan Li et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)

Article Clinical Neurology

Dysphagia in multiple sclerosis - prevalence and prognostic factors

P Calcagno et al.

ACTA NEUROLOGICA SCANDINAVICA (2002)

Article Geriatrics & Gerontology

Aspiration pneumonia: Dental and oral risk factors in an older veteran population

MS Terpenning et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)

Review Medicine, General & Internal

Primary care: Aspiration pneumonitis and aspiration pneumonia.

PE Marik

NEW ENGLAND JOURNAL OF MEDICINE (2001)